![](https://endpts.com/wp-content/uploads/2021/04/Vas-Narasimhan-getty-scaled.jpg)
Vas Narasimhan, Novartis CEO (Simon Dawson/Bloomberg via Getty Images)
Novartis' radiopharma drug wins approval in tough-to-treat prostate cancer patients
One of the key ways in which Novartis CEO Vas Narasimhan hopes to stave off generic competition took a giant leap forward Wednesday afternoon. …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.